Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Generic Oncology Drugs Market Segmentation Analysis: Insights by Drug Type, Indication, and Distribution ChannelThe global generic oncology drugs market is structured across multiple segments that reflect the diversity of cancer treatments and the evolving needs of patients and healthcare providers. Increasing demand for cost-effective therapies and the growing prevalence of various cancer types are driving growth across all segments. Generic Oncology Drugs Market Segmentation Analysis provides...0 Комментарии 0 Поделились 724 Просмотры 0 предпросмотр
-
Kirsten Rat Sarcoma (KRAS) Market: Targeted Therapies, Next-Generation Inhibitors (G12C), and Oncology Drug Development"Executive Summary Kirsten Rat Sarcoma (KRAS) Market Size and Share: Global Industry Snapshot Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market report offers the most appropriate solution for the...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
MENA Generic Oncology Drug Market, Size, Share, Growth and forecast (2024-2032)According to the UnivDatos, the growing awareness of generic medicines in the region will drive the scenario of Generic Oncology Drugs and as per their “MENA Generic Oncology Drug Market” report, the Saudi Arabia Market was valued at USD ~4 billion in 2022, growing at a CAGR of 3% during the forecast period from 2024 - 2032 to reach USD billion by 2030. The Saudi Arabia region is...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Rhabdomyosarcoma Treatment Market: Drug Pipeline, Chemotherapy and Radiation Strategies, and Pediatric Oncology LandscapeThe Global Rhabdomyosarcoma (RMS) Treatment Market is a highly specialized segment within the global oncology and pediatric medicine industry. RMS is a rare but aggressive form of cancer that originates in mesenchyme cells, which normally develop into skeletal muscle. The market encompasses all therapeutic modalities, including chemotherapy, radiation therapy, surgery, and emerging targeted and...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Комментарии 0 Поделились 7Кб Просмотры 0 предпросмотр
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cervical Cancer Therapeutics Market Future Growth ProspectsThe global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...0 Комментарии 0 Поделились 675 Просмотры 0 предпросмотр
-
Global High Potent API (HPAPI) Market — Trends and Market Leaders & Key Company ProfilesThe global high potent API (HPAPI) market is experiencing exceptional growth momentum, driven by the surging demand for targeted cancer therapies, rapid advancements in containment and manufacturing technologies, and a structural shift toward outsourced pharmaceutical production. According to The Insight Partners, the high potent API market was valued at US$ 28.82 Billion in...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Global Somatostatin Analogs Market Poised for Steady Growth.The global somatostatin analogs market is experiencing robust growth, fueled by the increasing prevalence of hormonal disorders such as acromegaly and neuroendocrine tumors. These synthetic peptides mimic natural somatostatin, a hormone that inhibits the release of several other hormones, thus playing a crucial role in managing complex endocrine conditions. Market Drivers One of the...0 Комментарии 0 Поделились 6Кб Просмотры 0 предпросмотр
-
How Are Treatments Advancing in Metastatic Solid Tumors Market?Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
